Back to Browse Journals » Clinical Interventions in Aging » Volume 2 » Issue 4

Testosterone replacement therapy for older men

Authors Stephen E Borst, Thomas Mulligan

Published Date January 2007 Volume 2007:2(4) Pages 561—566

DOI http://dx.doi.org/10.2147/CIA.S1609

Published 3 January 2007

Stephen E Borst, Thomas Mulligan

Geriatrics Research, Education, and Clinical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL, USA

Abstract: Despite intensive research on testosterone therapy for older men, important questions remain unanswered. The evidence clearly indicates that many older men display a partial androgen deficiency. In older men, low circulating testosterone is correlated with low muscle strength, with high adiposity, with insulin resistance and with poor cognitive performance. Testosterone replacement in older men has produced benefits, but not consistently so. The inconsistency may arise from differences in the dose and duration of testosterone treatment, as well as selection of the target population. Generally, studies reporting anabolic responses to testosterone have employed higher doses of testosterone for longer treatment periods and have targeted older men whose baseline circulating bioavailable testosterone levels were low. Most studies of testosterone replacement have reported anabolic that are modest compared to what can be achieved with resistance exercise training. However, several strategies currently under evaluation have the potential to produce greater anabolic effects and to do so in a safe manner. At this time, testosterone therapy can not be recommended for the general population of older men. Older men who are hypogonadal are at greater risk for the catabolic effects associated with a number of acute and chronic medical conditions. Future research is likely to reveal benefits of testosterone therapy for some of these special populations. Testosterone therapy produces a number of adverse effects, including worsening of sleep apnea, gynecomastia, polycythemia and elevation of PSA. Efficacy and adverse effects should be assessed frequently throughout the course of therapy.
Keywords: aging, testosterone, hypogonadism, physical function

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Lebrikizumab in the personalized management of asthma

Thomson NC, Patel M, Smith AD

Biologics: Targets and Therapy 2012, 6:329-335

Published Date: 14 September 2012

The bradykinin B2 receptor induces multiple cellular responses leading to the proliferation of human renal carcinoma cell lines

Kramarenko II, Morinelli TA, Bunni MA, Raymond JR Sr, Garnovskaya MN

Cancer Management and Research 2012, 4:195-205

Published Date: 26 July 2012

Concentration-dependent effects of fullerenol on cultured hippocampal neuron viability

Zha YY, Yang B, Tang ML, Guo QC, Chen JT, Wen LP, Wang M

International Journal of Nanomedicine 2012, 7:3099-3109

Published Date: 29 June 2012

VGLUT2 mRNA and protein expression in the visual thalamus and midbrain of prosimian galagos (Otolemur garnetti)

Pooja Balaram, Toru Takahata, Jon H Kaas

Eye and Brain 2011, 3:5-15

Published Date: 21 March 2011

Antipsychotic adherence, switching, and health care service utilization among Medicaid recipients with schizophrenia

Douglas L Noordsy, Glenn A Phillips, Daniel E Ball, et al

Patient Preference and Adherence 2010, 4:263-271

Published Date: 20 July 2010

Multifocal conjunctival leaks due to the use of mitomycin C mimicking the normal drainage of the tear from the lacrimal excretory ducts

Burak Turgut, Murat Kaya, Tamer Demir, et al

Clinical Optometry 2010, 2:55-57

Published Date: 1 June 2010

The benefits and risks of testosterone replacement therapy: a review

Nazem Bassil, Saad Alkaade, John E Morley

Therapeutics and Clinical Risk Management 2009, 5:427-448

Published Date: 11 June 2009

The cognitive impact of anticholinergics: A clinical review

Noll Campbell, Malaz Boustani, Tony Limbil, Carol Ott, et al.

Clinical Interventions in Aging 2009, 4:225-233

Published Date: 13 May 2009

Diffuse iris melanoma: Report of a case with review of the literature

Simon E Skalicky, Michael Giblin, R Max Conway

Clinical Ophthalmology 2007, 1:339-342

Published Date: 3 December 2007